Diagnosis Of Neurodegenerative Diseases
I am looking to speak with market/business strategy consultants having specific knowledge of diagnostic market of the following neurodegenerative diseases - alzheimer’s diseases, parkinson’s disease and multiple sclerosis.
Please respond with a few brief statements regarding your background/relevant experience related to alzheimer’s disease, parkinson’s disease or multiple sclerosis and blood based diagnostic methods used to diagnose them.
+15 Other Responses
Spasticity Treatment And Management
We would like to speak with multiple experts who have in-depth knowledge as neurologists, physiatrist, or kols and high-volume prescribers focusing on spasticity.
We are interested in learning about the treatment and management of spasticity patients in the us.
This is a paid 1-hr in-depth online interview. To show your relevance in this space, please answer the questions below and briefly discuss your insights:
can you discuss your expertise in spasticity as a neurologist or physiatrist? Please discuss briefly.
**please note that we are only interested in your personal point of view and are not seeking confidential information.
***referrals are highly appreciated
+7 Other Responses
Need an industry expert on immunology market. He/she should have extensive knowledge on one of these market segments such as:
glucocorticoids, non-biologic disease modifying drugs and biologics;
ankylosing spondylitis, crohn’s disease, multiple sclerosis, psoriasis, rheumatoid arthritis, systemic lupus erythematosus, ulcerative colitis;
tumor necrosis factor- alpha, interleukin-6 and receptor, interleukin – 1,2,5,12,17 & 23 and receptors)
(humira (adalimumab), remicade (infliximab), enbrel (etanercept), rituxan (rituximab), stelara (ustekinumab), progra (tacrolimus), cimzia (certolizumab pegol), simponi (golimumab), entyvio (vedolizumab).
The expert should be able to provide insights on the following for the above: market size, company shares, market trends, and price trends. As well as knowledge regarding country-wide usage for us and europe regarding the price trends and market shares will be helpful.
+12 Other Responses